Display Settings:

Format

Send to:

Choose Destination
    Genetics. 2006 Apr;172(4):2309-24. Epub 2006 Jan 16.

    Presenilin-based genetic screens in Drosophila melanogaster identify novel notch pathway modifiers.

    Source

    Exelixis, South San Francisco, California 94083.

    Abstract

    Presenilin is the enzymatic component of gamma-secretase, a multisubunit intramembrane protease that processes several transmembrane receptors, such as the amyloid precursor protein (APP). Mutations in human Presenilins lead to altered APP cleavage and early-onset Alzheimer's disease. Presenilins also play an essential role in Notch receptor cleavage and signaling. The Notch pathway is a highly conserved signaling pathway that functions during the development of multicellular organisms, including vertebrates, Drosophila, and C. elegans. Recent studies have shown that Notch signaling is sensitive to perturbations in subcellular trafficking, although the specific mechanisms are largely unknown. To identify genes that regulate Notch pathway function, we have performed two genetic screens in Drosophila for modifiers of Presenilin-dependent Notch phenotypes. We describe here the cloning and identification of 19 modifiers, including nicastrin and several genes with previously undescribed involvement in Notch biology. The predicted functions of these newly identified genes are consistent with extracellular matrix and vesicular trafficking mechanisms in Presenilin and Notch pathway regulation and suggest a novel role for gamma-tubulin in the pathway.

    PMID:
    16415372
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1456381
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Figure 2.
    Figure 4.
    Figure 1.
    Figure 3.
    Figure 5.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk